Morgan Stanley’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.8M | Buy |
|
|||||
2025
Q1 | $6.47M | Buy |
|
|||||
2024
Q4 | $13.8M | Buy |
|
|||||
2024
Q3 | $13.3M | Buy |
|
|||||
2024
Q2 | $5.26M | Buy |
|
|||||
2024
Q1 | $4.2M | Buy |
|
|||||
2023
Q4 | $2.32M | Buy |
|
|||||
2023
Q3 | $582K | Buy |
|
|||||
2023
Q2 | $663K | Sell |
|
|||||
2023
Q1 | $924K | Sell |
|
|||||
2022
Q4 | $2.24M | Buy |
|
|||||
2022
Q3 | $3.02M | Sell |
|
|||||
2022
Q2 | $3.43M | Sell |
|
|||||
2022
Q1 | $16M | Sell |
|
|||||
2021
Q4 | $29.6M | Buy |
|
|||||
2021
Q3 | $13M | Buy |
|
|||||
2021
Q2 | $10.5M | Buy |
|
|||||
2021
Q1 | $784K | Buy |
|
|||||
2020
Q4 | $302K | Buy |
|